[1]
S. K. Singh and P. Sachan, “A prospective observational study on efficacy of serial low dose infusion of rituximab (500 mg) on patients of pemphigus”, Int J Res Dermatol, vol. 6, no. 5, pp. 622–627, Aug. 2020.